840
Participants
Start Date
January 2, 2023
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2026
Vasopressin
The infusion is started at 5 ml hr-1, increased in increments of 1 ml hr-1 every 5 minutes to reach a maximum target rate of 30 ml hr-1
Norepinephrine
The infusion is started at 5 ml h-1, increased in increments of 1 ml h-1 every 5 minutes to a maximum target rate of 30 ml h-1
Collection of clinical data
At D1, D2, D7, D30 or D60 and D90
Quality of Life Questionnaire EQ-5D
At the anesthesia consultation, discharge from intensive care, D7, D30 and D90
RECRUITING
Chu Dijon Bourgogne, Dijon
Centre Hospitalier Universitaire Dijon
OTHER